Meet The Team

Dr Katie Newman

PhD

Dr Katie Newman has a background in neuroscience and cell-based in vitro models. After working on a rat model of hyperglycaemia during her MSc Katie developed a strong wish to reduce the use of animals in research. Her PhD  involved investigating the causes of genetic small vessel disease (SVD) by developing an alternative in vitro approach with induced pluripotent stem cells (iPSC) and CRISPR gene editing technology. Katie is a great team-player who wants to contribute to bringing life-saving drugs on the market.

Read more Katie Newman